EligibleTrials

Drugs and treatments in recruiting clinical trials

730 interventions with 3+ recruiting trials.

Browse by intervention

InterventionRecruiting trials
Pembrolizumab192
Carboplatin173
Bevacizumab97
Docetaxel96
Cyclophosphamide93
Capecitabine89
Paclitaxel88
Nab-paclitaxel85
Pemetrexed84
Gemcitabine80
Nivolumab76
Cisplatin70
Oxaliplatin64
Atezolizumab55
Tirzepatide55
Fludarabine53
Fulvestrant52
Durvalumab49
Cetuximab47
Enzalutamide45
Metformin45
Trastuzumab45
Semaglutide43
Osimertinib41
Abemaciclib39
Irinotecan38
Cemiplimab36
Letrozole36
Ipilimumab33
Etoposide32
Fluorouracil32
Pertuzumab32
Prednisone32
Trastuzumab deruxtecan32
Sintilimab31
Tislelizumab31
Leucovorin29
Stereotactic Body Radiation Therapy28
Olaparib27
Ribociclib27
Ketamine26
SBRT26
Toripalimab25
Darolutamide24
Psilocybin23
Dupilumab22
Methotrexate22
Palbociclib22
Empagliflozin21
Sacituzumab govitecan21
Pyrotinib20
Rituximab20
Abiraterone Acetate19
Ivonescimab19
Serplulimab19
Tamoxifen19
Abiraterone18
Apalutamide18
Aspirin18
Doxorubicin18
Epirubicin18
Everolimus18
Dexamethasone17
Guselkumab17
Adebrelimab16
Anastrozole16
Androgen Deprivation Therapy (ADT)16
BL-B01D116
Elacestrant16
Immunotherapy16
Infliximab16
5-Fluorouracil15
Blood sampling15
Empagliflozin 10 MG15
Exemestane15
Fruquintinib15
KarXT15
mFOLFIRINOX15
Panitumumab15
Pumitamig15
Tarlatamab15
Aldesleukin14
Camrelizumab14
Dapagliflozin14
Midazolam14
Propofol14
Stereotactic Body Radiation Therapy (SBRT)14
Vedolizumab14
Apixaban13
Eribulin13
FOLFOX13
Sirolimus13
Upadacitinib13
Dexmedetomidine12
FOLFIRI12
Interleukin-212
Ketamine Hydrochloride12
Lurbinectedin12
Methylphenidate12
Probiotic12
Probiotics12
Sacituzumab tirumotecan12
Topotecan12
Ustekinumab12
Anlotinib11
Balstilimab11
Dalpiciclib11
Deucravacitinib11
Empagliflozin 25 MG11
Endocrine therapy11
Fluoxetine11
Hypofractionated Radiation Therapy11
Inavolisib11
NNC0487-011111
Pioglitazone11
Risankizumab11
Sotorasib11
Temozolomide11
Adalimumab10
Alemtuzumab10
Amivantamab10
Binimetinib10
Carvedilol10
Dapagliflozin 10mg Tab10
Denosumab10
Encorafenib10
Escitalopram10
Finerenone10
Furmonertinib10
Lutetium Lu 177 Vipivotide Tetraxetan10
Short-course radiotherapy10
SHR-A181110
ADT9
Afimkibart9
BL-M07D19
Botensilimab9
Cannabidiol9
Degarelix9
Elecoglipron9
Eloralintide9
Esketamine9
Goserelin9
Immune checkpoint inhibitor9
Olanzapine9
Pembrolizumab (KEYTRUDA®)9
Ramucirumab9
Relugolix9
Rilvegostomig9
Sertraline9
SGLT2 inhibitor9
Spironolactone9
Stereotactic Body Radiotherapy9
Tocilizumab9
Total Body Irradiation9
Tremelimumab9
Trifluridine-Tipiracil9
Ublituximab9
Vinorelbine9
Zanidatamab9
Abrocitinib8
Adagrasib8
Adjuvant chemotherapy8
Androgen Deprivation Therapy8
Anifrolumab8
Cabazitaxel8
Capivasertib8
Datopotamab Deruxtecan8
Maridebart cafraglutide8
mFOLFOX68
Mirikizumab8
Pembrolizumab injection8
Prednisolone8
Rescue Medication8
Sacubitril / Valsartan8
Tezepelumab8
5-FU7
Albumin-Bound Paclitaxel7
AlloRx7
Atorvastatin7
Azathioprine7
Cadonilimab7
Clozapine7
Colchicine7
daraxonrasib7
Dato-DXd7
Dostarlimab7
Folfirinox7
Fulvestrant injection7
gemcitabine + nab-paclitaxel7
Hydroxychloroquine7
Hydroxyurea7
Hypofractionated Radiotherapy7
Indocyanine Green7
Keytruda7
Lenvatinib7
Leuprolide7
Levetiracetam7
Mesalamine7
Methylprednisolone7
Mycophenolate Mofetil7
NMDAE7
Ocrelizumab7
Orforglipron7
Ozanimod7
Platinum based chemotherapy7
Pregabalin7
QL17067
Regorafenib7
Stereotactic body radiotherapy (SBRT)7
Talazoparib7
Telisotuzumab Adizutecan7
Tofacitinib7
Tucatinib7
Vitamin D7
Vitamin D37
18F-DCFPyL6
Acetazolamide6
AK1126
Alectinib6
Apatinib6
Atomoxetine6
Baricitinib6
Belimumab6
Bicalutamide6
Cabozantinib6
Cagrilintide6
Camizestrant6
Capecitabine tablets6
CAPOX6
Carboplatin (AUC 5)6
CBD6
CDK4/6 inhibitor6
Celecoxib6
Dabrafenib6
Dapagliflozin 10 mg6
Depemokimab6
Famitinib6
Fluzoparib6
Giredestrant6
GLP-1 receptor agonist6
High-Dose Rate Brachytherapy6
Ifinatamab deruxtecan6
Inclisiran6
Inulin6
Itraconazole6
Leflunomide6
Letrozole 2.5mg6
Liraglutide6
Lorlatinib6
Low-dose radiotherapy6
Maltodextrin6
Melatonin6
Neoadjuvant Chemotherapy6
Neratinib6
Nicotinamide6
Nivolumab + Relatlimab6
PD-1 Monoclonal Antibody6
Peg-IFNα6
PF-086344046
Retifanlimab6
Rezvilutamide6
Rivaroxaban6
Sacituzumab Govitecan (SG)6
Semaglutide Pen Injector6
SHR-A21026
Sotatercept6
Sunvozertinib6
Tebentafusp6
Testosterone cypionate6
Thiotepa6
Trametinib6
Tranexamic Acid6
Triptorelin6
Tumor Infiltrating Lymphocytes (TIL)6
UBT2516
Zasocitinib6
ZG0066
177Lu-PSMA-6175
18F-FDG5
Abraxane5
Adjuvant Radiotherapy5
AHB-1375
Anti-PD-1 monoclonal antibody5
Bempedoic acid5
BET Bromodomain Inhibitor ZEN-36945
Bimekizumab5
Blood test5
Carboplatin Injection5
CEA-targeted CAR-T cells5
Ceralasertib5
Chemotherapy drug5
Cobimetinib5
Crizotinib5
Datopotamab Deruxtecan (Dato-DXd)5
Disitamab vedotin5
Docetaxel injection5
Dolutegravir5
Donanemab5
Enavogliflozin5
Etanercept5

Showing the 300 most-studied of 730 interventions.

Also browse conditions with recruiting trials or the clinical trial statistics.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.